Mucositis: Its occurrence, consequences, and treatment in the oncology setting

Oncologist

Volumn 3, Issue 6, 1998, Pages 446-451

  Pico, José Luis ^a   Avila Garavito, Andrés ^a   Naccache, Philippe ^a  

^a INSTITUT GUSTAVE ROUSSY   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; CYCLOPHOSPHAMIDE; CYTARABINE; DOXORUBICIN; ETOPOSIDE; FLUOROURACIL; FOLINIC ACID; MELPHALAN; METHOTREXATE;

ARTICLE; BONE MARROW SUPPRESSION; CANCER CHEMOTHERAPY; HUMAN; MOUTH HYGIENE; MOUTH MUCOSA; MUCOSA INFLAMMATION; NEUTROPENIA; PRIORITY JOURNAL; QUALITY OF LIFE;

EID: 0032419292     PISSN: 10837159     EISSN: None     Source Type: Journal    
DOI: 10.1634/theoncologist.3-6-446     Document Type: Article

References (20)

1. Sonis S, Clark J. Prevention and management of oral mucositis induced by antineoplastic therapy. Oncology 1991;5:11-18.
2. Sonis S. Oral complications. In: Holland JF, Frei E III, Bast RC Jr., eds. Cancer Medicine, 4th Edition. Philadelphia: Lea & Febiger 1997;3255-3264.
3. Schubert M, Sullivan K, Truelove E. Head and neck complication of bone marrow transplantation. Development Oncology 1991;36:401-427.
4. Woo SB, Sonis ST, Monopoli MM et al. A longitudinal study of oral ulcerative mucositis in bone marrow transplant recipients. Cancer 1993;72:1612-1617.
5. McGuire DB, Altomonte V, Peterson DE et al. Patterns of mucositis and pain in patients receiving preparative chemotherapy and bone marrow transplantations. Oncol Nurs Forum 1993;20:1493-1502.
6. Elting LS, Bodey GP, Keefe BH. Septicemia and shock syndrome due to viridans streptococci: a case control study of predisposing factors. Clin Infect Dis 1992;14:1201-1207.
7. Peters LJ, Ang KK, Thames HD. Altered fractionation schedules. In: Perez CA, Brady LW, eds. Principles and Practice of Radiation Oncology. Philadelphia: JB Lippincott 1992;97-113.
8. Ruescher TJ, Sodeifi A, Scrivani SJ et al. The impact of mucositis on alpha-hemolytic streptococcal infections in patients undergoing autologous bone marrow transplantation for hematologic malignancies. Cancer 1998;82:2275-2281.
9. Guggenheimer J, Verbin RS, Apple BN et al. Clinco-pathologic effects of cancer chemotherapeutic agents on human buccal mucosa. Oral Surg Oral Med Oral Pathol 1997;44:58-63.
10. Lockhart PB, Sonis ST. Alterations in the oral mucosa caused by chemotherapeutic agents. A histologic study. J Dermatol Surg Oncol 1981;7:1019-1025.
11. Squier CA. Mucosal alterations. NCI Monograph 1990;9:169-172.
12. Sonis ST. Mucositis as a biological process: a new hypothesis for the development of chemotherapy-induced stomatotoxicity. Oral Oncol 1998,34:39-43.
13. Sonis ST, Lindquist L, VanVugt A et al. Prevention of chemotherapy-induced ulcerative mucositis by transforming growth factor beta 3. Cancer Res 1994:54:1135-1138.
14. Cope PO, DeMeo M, Stiff P et al. Prophylactic enterai support to BMT patients reduces length of hospital stay, improves GI integrity and nutritional status, and reduces intake requirements required for positive outcome. Proc ASCO 1997;16:218a.
15. Greenberg MS, Friedman H, Cohen SO et al. A comparative study of herpes simplex infections in renal transplant and leukemic patients. J Infect Dis 1987;156:280-287.
16. Yeo E, Alvarado T, Fainstein V et al. Prophylaxis of oropharyngeal candidiasis with clofrimazole. J Clin Oncol 1985;3:1668-1671.
17. Schubert MM. Measurement of oral tissue damage and mucositis pain. In: Chapman CR, Foley KH, eds. Current and Emerging Issues on Cancer Pain: Research and Practice. New York: Raven Press 1993;247-265.
18. Parulekar W, Mackenzie R, Bjarnason G et al. Scoring oral mucositis. Oral Oncol 1998:34:63-71.
19. Eilers J, Berger A, Petersen M. Development, testing, and application of the oral assessment guide. Oncol Nurs Forum 1988;15:325-330.
20. Mahood DJ, Dose AM, Loprinzi CL et al. Inhibition of 5-fluorouracil-induced mucositis by oral cryotherapy. J Clin Oncol 1991;9:449-452.